1Nattel SN, Adrianzen L, Kessler EC. (2017) Congenital Heart Disease and Neurodevelopment: Clinical Manifestations, Genetics, Mechanisms, and Implications. Can J Cardiol. 12:1543-1555.

2Simmons MA, Brueckner M. (2017) The genetics of congenital heart disease understanding and improving longterm outcomes in congenital heart disease: a review for the general cardiologist and primary care physician. Curr Opin Pediatr. 5:520-528.

3Cuneo BF. (2001) 22q11.2 deletion syndrome: Di- George, velocardiofacial, and conotruncal anomaly face syndromes. Curr Opin Pediatr. 5:465-472.

4Villafane J, Edwards TC, Diab KA. (2017) Development of quality metrics for ambulatory care in pediatric patients with tetralogy of Fallot. Congenit Heart Dis. 6:762-767.

5Pierpont ME, Basson CT, Benson DW. (2007) Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 23:3015-3038.

6Swillen A, McDonald-McGinn D. (2015) Developmental trajectories in 22q11.2 deletion. Am J Med Genet C Semin Med Genet. 2:172-181.

7Chowdhury D, Gurvitz M, Marelli A. (2017) Development of Quality Metrics in Ambulatory Pediatric Cardiology. J Am Coll Cardiol. 5:541-555.

8Hartwell LP, Baker AL, Jenkins KJ, de Ferranti SD, Saleeb SF. (2019) Experience participating in the American College of Cardiology Quality NetworkTM: paediatric and adult congenital cardiology collaborative quality improvement. Cardiol Young. 1:59-66.

9Marino BS, Lipkin PH, Newburger JW. (2012) Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 9:1143-1172.